BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35276041)

  • 1. Exposing the Brain Proteomic Signatures of Alzheimer's Disease in Diverse Racial Groups: Leveraging Multiple Data Sets and Machine Learning.
    Desaire H; Stepler KE; Robinson RAS
    J Proteome Res; 2022 Apr; 21(4):1095-1104. PubMed ID: 35276041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma.
    Khan MJ; Desaire H; Lopez OL; Kamboh MI; Robinson RAS
    J Alzheimers Dis; 2021; 79(3):1327-1344. PubMed ID: 33427747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion of African American/Black adults in a pilot brain proteomics study of Alzheimer's disease.
    Stepler KE; Mahoney ER; Kofler J; Hohman TJ; Lopez OL; Robinson RAS
    Neurobiol Dis; 2020 Dec; 146():105129. PubMed ID: 33049317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High performance plasma amyloid-β biomarkers for Alzheimer's disease.
    Nakamura A; Kaneko N; Villemagne VL; Kato T; Doecke J; Doré V; Fowler C; Li QX; Martins R; Rowe C; Tomita T; Matsuzaki K; Ishii K; Ishii K; Arahata Y; Iwamoto S; Ito K; Tanaka K; Masters CL; Yanagisawa K
    Nature; 2018 Feb; 554(7691):249-254. PubMed ID: 29420472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer's Disease.
    Tandon R; Levey AI; Lah JJ; Seyfried NT; Mitchell CS
    J Alzheimers Dis; 2023; 92(2):411-424. PubMed ID: 36776048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics.
    Gaetani L; Bellomo G; Parnetti L; Blennow K; Zetterberg H; Di Filippo M
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease.
    Ashton NJ; Nevado-Holgado AJ; Barber IS; Lynham S; Gupta V; Chatterjee P; Goozee K; Hone E; Pedrini S; Blennow K; Schöll M; Zetterberg H; Ellis KA; Bush AI; Rowe CC; Villemagne VL; Ames D; Masters CL; Aarsland D; Powell J; Lovestone S; Martins R; Hye A
    Sci Adv; 2019 Feb; 5(2):eaau7220. PubMed ID: 30775436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multiplexed Urinary Biomarker Panel Has Potential for Alzheimer's Disease Diagnosis Using Targeted Proteomics and Machine Learning.
    Hällqvist J; Pinto RC; Heywood WE; Cordey J; Foulkes AJM; Slattery CF; Leckey CA; Murphy EC; Zetterberg H; Schott JM; Mills K; Paterson RW
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advent of Proteomic Tools for Diagnostic Biomarker Analysis in Alzheimer's Disease.
    Singh M; Singh SP; Dubey PK; Rachana R ; Mani S; Yadav D; Agarwal M; Agarwal S; Agarwal V; Kaur H
    Curr Protein Pept Sci; 2020; 21(10):965-977. PubMed ID: 32538723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic and biological profiling of extracellular vesicles from Alzheimer's disease human brain tissues.
    Muraoka S; DeLeo AM; Sethi MK; Yukawa-Takamatsu K; Yang Z; Ko J; Hogan JD; Ruan Z; You Y; Wang Y; Medalla M; Ikezu S; Chen M; Xia W; Gorantla S; Gendelman HE; Issadore D; Zaia J; Ikezu T
    Alzheimers Dement; 2020 Jun; 16(6):896-907. PubMed ID: 32301581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iTRAQ-based Proteomic Analysis of APPSw,Ind Mice Provides Insights into the Early Changes in Alzheimer's Disease.
    Li N; Hu P; Xu T; Chen H; Chen X; Hu J; Yang X; Shi L; Luo JH; Xu J
    Curr Alzheimer Res; 2017; 14(10):1109-1122. PubMed ID: 28730955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic Profiling of Plasma and Brain Tissue from Alzheimer's Disease Patients Reveals Candidate Network of Plasma Biomarkers.
    Chen M; Xia W
    J Alzheimers Dis; 2020; 76(1):349-368. PubMed ID: 32474469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing fluid biomarkers of Alzheimer's disease between African American or Black African and white groups: A systematic review and meta-analysis.
    Chaudhry A; Rizig M
    J Neurol Sci; 2021 Feb; 421():117270. PubMed ID: 33349466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer's Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach.
    Li J; Bur AM; Villwock MR; Shankar S; Palmer G; Sykes KJ; Villwock JA
    J Alzheimers Dis; 2021; 81(2):641-650. PubMed ID: 33843686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
    Chang CH; Lin CH; Lane HY
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
    Hampel H; Bürger K; Teipel SJ; Bokde AL; Zetterberg H; Blennow K
    Alzheimers Dement; 2008 Jan; 4(1):38-48. PubMed ID: 18631949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks.
    Zhang Y; Ghose U; Buckley NJ; Engelborghs S; Sleegers K; Frisoni GB; Wallin A; Lleó A; Popp J; Martinez-Lage P; Legido-Quigley C; Barkhof F; Zetterberg H; Visser PJ; Bertram L; Lovestone S; Nevado-Holgado AJ; Shi L
    Front Aging Neurosci; 2022; 14():1040001. PubMed ID: 36523958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.